Purpose Identifying mutations in breast cancer genes (BRCA1, BRCA2, PABL2) has important clinical implications on a woman's lifetime susceptibility to breast cancer development. Nearly 10% of immigrants ... cancer…
Cofactor of BRCA1 (COBRA1) is a BRCA1 interacting protein that represents one of the four subunits of the negative elongation factor (NELF) complex. NELF is known by its ability
Mutations of the breast cancer susceptibility genes brca1 and brca2 account for 30âÂ?Â?50% of hereditary breast and ovarian cancer cases reported worldwide. The brca1 gene is the most ... large number of mis-sense…
young women breast cancer is limited and the cancer characteristics mutation BRCA1/A2 genes are less well studied. This study was aimed to provide the first data on young women ... between January 2009 and December…
between poly (ADP-ribose) polymerase 1/2 proteins and DNA damage response genes including BRCA1, a factor involved in homologous recombinationâ????mediated DNA repair and CDK12, a transcriptional kinase known ... been…
nutritional, environmental and genetic factors. Genes play an important role in BC diagnosis are BRCA1/2 genes. In the Czech statistics, the lifetime cumulative risk of BC with confirmed mutations ... BRCA1/2 genes…
Mutations in the BRCA1/2 genes are associated with an increased risk of breast cancer, but no large-scale research have examined the BRCA1/2 mutations in Chinese Kazakh women ... evaluated the frequency and…
Specific inherited mutations in BRCA1 increases the risk of female breast and ovarian cancers. BRCA1 critically maintains genome stability and cell cycle progression. BRCA1 is a well-known tumor suppressor ... confer…
BRCA1 mutation carriers have an increased lifetime risk of serous epithelial ovarian cancer (EOC), as well as breast cancer, but reasons for this increased risk remain elusive. We hypothesized that ... reported…
environmental factors. Among these, the interplay between estrogen signaling and the tumor suppressor gene BRCA1 has garnered significant attention due to their individual roles in breast cancer etiology. Estrogen…
Background: Many BRCA1 and BRCA2 mutations have been characterized in breast cancer subjects; however, the overall prevalence in Latin American remains elusive. The aim of the study was to determine ... prevalence of…
uncertain. This study assesses benefits and harms of prophylactic RRSO in women with BRCA1 or BRCA2 mutations. Method: We searched Cochrane Central Register of Controlled Trials, MEDLINE /Embase Ovid ... statistic. We…
Role of BRCA1 and PARP1 has been studied by immunohistochemistry in a cohort of ovarian cancers. Their expression has been related to overall survival and disease free disease. Objective ... outcome of an heterogeneous…
different families. Several mutations have been discovered across the full length of BRCA1 gene, and categorizing their pathogenicity is a major challenge. Carriers of BRCA1 mutations have an increased risk ... basis…
virus type 1) Tax oncoprotein is considered a key factor in HTLV-1 pathogenicity. BRCA1 gene dysfunction can lead to breast cancer development. In contrast to the tumor suppressor nature ... BRCA1, Tax is a potent…
high familial risk. The families in which the standard genetic testing revealed a BRCA1 or BRCA2 mutation were excluded to identify clinical characteristics that can be linked with an unknown ... those from patients in…
BRCA1 and BRCA2 are tumor suppressor genes that aid in non-homologous DNA repair. Germline pathogenic variants in these genes cause hereditary breast and ovarian cancer syndrome (HBOC). De novo ... pathogenic variants…
Statement of the Problem: Human BRCA1 encodes a tumor suppressor protein that repairs double-stranded DNA breaks in cells. Mutations in BRCA1 are closely linked to the early onset ... breast and ovarian cancers. BRCA1…
world which entails loss of function mutation in certain important tumor suppressor genes like BRCA1 and BRCA2. Among sporadic breast tumors, 50-70% has lost an allele of BRCA1 ... implying the idea of gene therapy this…
been categorized as tumor suppressors that are often repressed by aberrant DNA methylation. Recently, BRCA1 promoter methylation in White Blood Cells (WBC) has been linked to elevated risk of developing ... present…
examined mRNA expression levels of ERCC1, BRCA1, RRM1, and human β-tubulin-III (TUBB3) in non-small-cell lung carcinoma (NSCLC) patients and investigated the association between expression of these ... platinum-based…
Germline mutations in the BRCA1 gene are known predictive markers for the development of hereditary breast cancer. Nevertheless, no comprehensive study has been performed targeting the presence and relevance ... BRCA1…
polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk ... developing…
polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk ... developing…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.